Marketplace Morning Report

with David Brancaccio

Marketplace Morning Report for Thursday, April 11, 2013

Biogen Idec, a Massachusetts-based biotech company, is hoping its new multiple sclerosis drug Tecfidera will eventually bring in the hundreds of millions of dollars it cost to develop -- at least before a generic comes along and copies it. CEO George Scangos discusses his company's development process and pricing strategy. A new report from the research firm IDC says personal computer sales are falling fast all around the world. And in Phoenix, Arizona, new signs of a real estate bubble are emerging.

Listen to the episode
Download

From this Episode

Music from this Show

Browse the Show
David Brancaccio
Brancaccio david

About the Show

Marketplace Morning Report®, hosted by David Brancaccio, kicks your weekday off right. Now a regular segment on NPR’s Morning Edition®, it’s a dash of news to go with that first cup of coffee. Get a global perspective on what’s making the business news headlines, airing up to five times each morning.